Gregory L. Jackson
Known title: DirectorCIK: 0001450235
Associated companies
Transaction History
| PRDO | ▼ Sell | Open Market | 11,271 | $358K | 8/11/2026 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 11,271 | $109K | 8/11/2026 | View on chart |
| PRDO | ▲ Buy | Grant | 3,987 | $0 | 5/21/2026 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 4,568 | $27K | 8/27/2025 | View on chart |
| PRDO | ▼ Sell | Open Market | 4,568 | $148K | 8/27/2025 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 16,561 | $99K | 8/25/2025 | View on chart |
| PRDO | ▼ Sell | Open Market | 16,561 | $555K | 8/25/2025 | View on chart |
| PRDO | ▲ Buy | Grant | 5,155 | $0 | 5/22/2025 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 26,664 | $105K | 8/6/2024 | View on chart |
| PRDO | ▼ Sell | Open Market | 26,664 | $605K | 8/6/2024 | View on chart |
| PRDO | ▲ Buy | Grant | 6,256 | $0 | 5/23/2024 | View on chart |
| PRDO | ▲ Buy | Grant | 7,827 | $0 | 5/25/2023 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 4,174 | $12K | 3/2/2023 | View on chart |
| PRDO | ▼ Sell | Open Market | 4,174 | $57K | 3/2/2023 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 11,826 | $33K | 3/1/2023 | View on chart |
| PRDO | ▼ Sell | Open Market | 11,826 | $163K | 3/1/2023 | View on chart |
| PRDO | ▲ Buy | Grant | 9,050 | $0 | 5/26/2022 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 8,000 | $52K | 3/2/2022 | View on chart |
| PRDO | ▼ Sell | Open Market | 8,000 | $86K | 3/2/2022 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 8,000 | $52K | 3/1/2022 | View on chart |
| PRDO | ▼ Sell | Open Market | 8,000 | $84K | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 24, 2026
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline
Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline. Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.